Status:
COMPLETED
Impact of CMV Status on HIV Viral Load Decay
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Hiv
Eligibility:
All Genders
18+ years
Brief Summary
Background: Cytomegalovirus (CMV) infection is usually observed among patients with HIV infection. No study to date has investigated the impact of CMV infection on HIV viral load decay during antiretr...
Eligibility Criteria
Inclusion
- HIV patients starting an antiretroviral therapy
- CMV serology available at antiretroviral therapy initiation
- HIV viral load assessed at each follow-up visit after treatment initiation
Exclusion
- HIV antiretroviral treatment initiation before June 2005
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 30 2017
Estimated Enrollment :
345 Patients enrolled
Trial Details
Trial ID
NCT03349359
Start Date
November 1 2016
End Date
January 30 2017
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Croix-Rousse Hospital, Hospices Civils de Lyon
Lyon, France, 69004